Innovation in Molecular Imaging Probes (R01)

Post Date

November 18th 2008

Application Due Date

September 21st 2011

Funding Opportunity Number

PAR-09-016

CFDA Number(s)

93.242
93.286
93.846
93.847
93.853
93.865
93.866

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health
Income Security and Social Services

Eligibility Categories

State Governments
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $None

Grant Description

Purpose This FOA is issued by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. This FOA is a follow up of a previous Roadmap RFA (RM-04-021 Innovation in Molecular Imaging Probes). The purpose of this initiative is to encourage the development of novel molecular imaging approaches that can detect and image specific molecular activities in vivo, and have the potential for clinical applications.Novel molecular imaging approaches developed through this initiative can focus on one (or both) of the following long-term translational goals: (1) imaging the characteristic markers, and function, of normal cells in control human subjects and patients, and (2) imaging the characteristic markers, and biochemical or physiological abnormalities, of disease cells in patients.Potential abnormalities that could provide early markers for disease include (but are not restricted to): inflammation, fibrosis, immune cell activation, altered signal transduction pathways, altered gene expression pathways, and altered post-translational modification of proteins.This initiative solicits applications that explore innovative high-impact approaches, rather than incremental technology development that is already supported by current NIH programs. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism with a 12 page limit for the research plan. Funds Available and Anticipated Number of Awards.Awards issued under this FOA are contingent upon the availability of funds.The total amount awarded and the number of grants will depend upon the quality, duration and costs of the applications received.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-09-016.html